1. Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 2010, 13:805-811. [
DOI:10.1038/nn.2575] [
PMID] [
PMCID]
2. Harris H, Rubinsztein DC. Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol 2011, 8:108-117. [
DOI:10.1038/nrneurol.2011.200] [
PMID]
3. Son JH, Shim JH, Kim KH, Ha JY, Han JY. Neuronal autophagy and neurodegenerative diseases. Exp Mol Med. 2012 Feb 29;44(2):89-98. [
DOI:10.3858/emm.2012.44.2.031] [
PMID] [
PMCID]
4. Schneider JL, Cuervo AM. Autophagy and human disease: emerging themes. Curr Opin Genet Dev 2014, 26:16-23. [
DOI:10.1016/j.gde.2014.04.003] [
PMID] [
PMCID]
5. Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell 2019, 176:11-42. [
DOI:10.1016/j.cell.2018.09.048] [
PMID] [
PMCID]
6. Robichaux MA, Cowan CW. Signaling mechanisms of axon guidance and early synaptogenesis. Curr Top Behav Neurosci 2014, 16: 19-48. [
DOI:10.1007/978-3-662-45758-0_255]
7. Korhonen L, Lindholm D. The ubiquitin-proteasome system in synaptic and axonal degeneration: a new twist to an old cycle. J Cell Biol 2004, 165: 27-30. [
DOI:10.1083/jcb.200311091] [
PMID] [
PMCID]
8. Morgado AL, Xavier JM, Dionisio PA, Ribeiro MF, Dias RB, Sebastiao AM, et al. MicroRNA-34a Modulates Neural Stem Cell Differentiation by Regulating Synaptic and Autophagic Proteins Expression. Mol Neurobiol 2014. [
DOI:10.1007/s12035-014-8794-6] [
PMID]
9. Petralia RS, Schwartz CM, Wang YX, Kawamoto EM, Mattson MP, Yao PJ. Sonic Hedgehog promotes autophagy in hippocampal neurons. Biol Open 2013, 2: 499-504. [
DOI:10.1242/bio.20134275] [
PMID] [
PMCID]
10. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012, 149:274-293. [
DOI:10.1016/j.cell.2012.03.017] [
PMID]
11. Hoeffer CA, Klann E. mTOR signaling: at the crossroads of plasticity, memory, and disease. Trends Neurosci 2010, 33:67-75. [
DOI:10.1016/j.tins.2009.11.003] [
PMID] [
PMCID]
12. Hernandez D, Torres CA, Setlik W, Cebrian C, Mosharov EV, Tang G, et al. Regulation of presynaptic neurotransmission by macroautophagy. Neuron 2012, 74: 277-284. [
DOI:10.1016/j.neuron.2012.02.020] [
PMID]
13. Dobashi Y, Watanabe Y, Miwa C, Suzuki S, Koyama S. Mammalian target of rapamycin: a central node of complex signaling cascades. Int J Clin Exp Pathol 2011, 4: 476-495.
14. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011, 13: 132-141. [
DOI:10.1038/ncb2152] [
PMID]
15. Liu-Yesucevitz L, Bassell GJ, Gitler AD, Hart AC, Klann E, Richter JD, et al. Local RNA translation at the synapse and in disease. J Neurosci 2011, 31: 16086-16093. [
DOI:10.1523/JNEUROSCI.4105-11.2011] [
PMID] [
PMCID]
16. Lyu D, Yu W, Tang N, Wang R, Zhao Z, Xie F, et al. The mTOR signaling pathway regulates pain-related synaptic plasticity in rat entorhinal-hippocampal pathways. Mol Pain 2013, 9: 64. [
DOI:10.1186/1744-8069-9-64] [
PMID] [
PMCID]
17. Shehata M, Matsumura H, Okubo-Suzuki R, Ohkawa N, Inokuchi K. Neuronal stimulation induces autophagy in hippocampal neurons that is involved in AMPA receptor degradation after chemical long-term depression. J Neurosci 2012;32: 10413-22. [
DOI:10.1523/JNEUROSCI.4533-11.2012] [
PMID] [
PMCID]
18. Lamming DW, Bar-Peled L. Lysosome: The metabolic signaling hub. Traffic. 2019 Jan;20(1):27-38. Epub 2018 Nov 14. [
DOI:10.1111/tra.12617] [
PMID] [
PMCID]
19. Joseph C. Roney, Xiu-Tang Cheng, Zu-Hang Sheng. Neuronal endolysosomal transport and lysosomal functionality in maintaining axonostasis. J Cell Biol 7 March 2022; 221 (3): e202111077. [
DOI:10.1083/jcb.202111077] [
PMID] [
PMCID]
20. Koh, JY., Kim, H.N., Hwang, J.J. et al. Lysosomal dysfunction in proteinopathic neurodegenerative disorders: possible therapeutic roles of cAMP and zinc. Mol Brain 12, 18 (2019). [
DOI:10.1186/s13041-019-0439-2] [
PMID] [
PMCID]
21. Malik BR, Maddison DC, Smith GA, Peters OM. Autophagic and endo-lysosomal dysfunction in neurodegenerative disease. Mol Brain. 2019 Nov 29;12(1):100. [
DOI:10.1186/s13041-019-0504-x] [
PMID] [
PMCID]
22. De Pace, R., Ghosh, S., Ryan, V.H. et al. Messenger RNA transport on lysosomal vesicles maintains axonal mitochondrial homeostasis and prevents axonal degeneration. Nat Neurosci 27, 1087-1102 (2024). [
DOI:10.1038/s41593-024-01619-1] [
PMID]
23. Smiles WJ, Ovens AJ, Kemp BE, Galic S, Petersen J, Oakhill JS. New developments in AMPK and mTORC1 cross-talk. Essays Biochem. 2024 Nov 18;68(3):321-336. [
DOI:10.1042/EBC20240007] [
PMID]
24. Alshial, E. E., Abdulghaney, M. I., Wadan, A.-H. S., Abdellatif, M. A., Ramadan, N. E., Suleiman, A. M., Waheed, N., Abdellatif, M., & Mohammed, H. S. Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview. Life Sciences, 2023, 334, 122257. [
DOI:10.1016/j.lfs.2023.122257] [
PMID]
25. Madkour, M. A., Altaf, R. A., Sayed, Z. S., Yasen, N. S., Elbary, H. A., Elsayed, R. A., Mohamed, E. N., Toema, M., Wadan, A. S., Nafady, M. H., & El-benhawy, S. A. Review Article The Role of Gut Microbiota in Modulating Cancer Therapy Efficacy. 2024. [
DOI:10.1155/2024/9919868]
26. Ellakwa, D. E.-S., Mushtaq, N., Khan, S., Jabbar, A., Abdelmalek, M. A., Wadan, A.-H. S., Ellakwa, T. E., & Raza, A. Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. [
DOI:10.1007/s00210-024-03076-w] [
PMID]
27. Mohamed, W., Kumar, J., Alghamdi, B. S., Soliman, A.-H., & Toshihide, Y. Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives. IBRO Neuroscience Reports, 2023,14, 95-110. [
DOI:10.1016/j.ibneur.2022.12.003] [
PMID] [
PMCID]
28. Safwat, L., Attia, Y. A. M., Mourad, S., Halawa, E. M., & Abd, N. H. The missing link between cancer stem cells and immunotherapy. Current Medical Research and Opinion, 2024(1), 1-22.
29. Sanaeifar, F., Pourranjbar, S., Pourranjbar, M., & Ramezani, S. Beneficial effects of physical exercise on cognitive-behavioral impairments and brain-derived neurotrophic factor alteration in the limbic system induced by neurodegeneration. Experimental Gerontology, 2024,195:112539. [
DOI:10.1016/j.exger.2024.112539] [
PMID]
30. Sayed, Z. S., Khattap, M. G., Madkour, M. A., Yasen, N. S., Elbary, H. A., Elsayed, R. A., Abdelkawy, D. A., Wadan, A.-H. S., Omar, I., & Nafady, M. H. Circulating tumor cells clusters and their role in Breast cancer metastasis; a review of literature. Discover Oncology, 2024,15(1), 94. [
DOI:10.1007/s12672-024-00949-7] [
PMID] [
PMCID]
31. Glatigny M, Moriceau S, Rivagorda M, Ramos-Brossier M, Nascimbeni AC, Lante F, et al. Autophagy Is Required for Memory Formation and Reverses Age-Related Memory Decline. Curr Biol 2019;29:435-448.e8. [
DOI:10.1016/j.cub.2018.12.021] [
PMID]
32. Nikoletopoulou V, Sidiropoulou K, Kallergi E, Dalezios Y, Tavernarakis N. Modulation of autophagy by BDNF underlies synaptic plasticity. Cell Metab 2017;26:230-242.e5. [
DOI:10.1016/j.cmet.2017.06.005] [
PMID]
33. Soliman, A.-H., & Abdellatif, M. (2023). COVID-19 disease treatment: pivotal challenges in the arena of umbilical cord-mesenchymal stem cells (UC-MSCs). Frontiers in Cell and Developmental Biology, 11, 1146835. [
DOI:10.3389/fcell.2023.1146835] [
PMID] [
PMCID]
34. Wadan AS, Raza ML, Moradikor N. Synaptic modulation by coffee compounds: Insights into neural plasticity. Progress in Brain Research. 2024a;289:181-191. [
DOI:10.1016/bs.pbr.2024.06.008] [
PMID]
35. Tolba, M. M., Jabbar, A., Afzal, S., Mahmoud, M., Zulfiqar, F., El-Soudany, I., Samir, S., Wadan, A.-H. S., Ellakwa, T. E., & Ellakwa, D. E.-S. A promising RNA nanotechnology in clinical therapeutics: a future perspective narrative review. Future Science OA, 2023,9(8), FSO883. [
DOI:10.2144/fsoa-2023-0067] [
PMID] [
PMCID]
36. Wadan, A. S., Abdelsattar, M., Hussein, A., Ellakwa, D. E., Hamed, N., & Gawish, A. The Interplay of Mitochondrial Dysfunction in Oral Diseases: Recent Updates in Pathogenesis and Therapeutic Implications. Mitochondrion, 2024b,78, 101942. [
DOI:10.1016/j.mito.2024.101942] [
PMID]
37. Yan J, Porch MW, Court-Vazquez B, Bennett MVL, Zukin RS. Activation of autophagy rescues synaptic and cognitive deficits in fragile X mice. Proc Natl Acad Sci USA 2018;115:E9707-16. [
DOI:10.1073/pnas.1808247115] [
PMID] [
PMCID]
38. Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011;12:9-14. [
DOI:10.1038/nrm3028] [
PMID]
39. Mochida K, Oikawa Y, Kimura Y, Kirisako H, Hirano H, Ohsumi Y, et al. Receptor-mediated selective autophagy degrades the endoplasmic reticulum and the nucleus. Nature 2015;522:359-62. [
DOI:10.1038/nature14506] [
PMID] [
PMCID]
40. Wadan, A. S., & Liaquat, M. Synaptic modulation by coffee compounds: Insights into neural plasticity. In Neuroscience of Coffee Part B (1st ed.). 2024,Elsevier B.V. [
DOI:10.1016/bs.pbr.2024.06.008] [
PMID]
41. Jaworski J, Sheng M. The growing role of mTOR in neuronal development and plasticity. Mol Neurobiol 2006;34:205-19. [
DOI:10.1385/MN:34:3:205] [
PMID]
42. Horwood JM, Dufour F, Laroche S, Davis S. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci 2006;23:3375-84. [
DOI:10.1111/j.1460-9568.2006.04859.x] [
PMID]
43. Panwar V, Singh A, Bhatt M, Tonk RK, Azizov S, Raza AS, Sengupta S, Kumar D, Garg M. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Ther. 2023 Oct 2;8(1):375. [
DOI:10.1038/s41392-023-01608-z] [
PMID]
44. Perluigi M, Di Domenico F, Butterfield DA. mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy. Neurobiol Dis. 2015 Dec;84: 39-49. [
DOI:10.1016/j.nbd.2015.03.014] [
PMID]
45. Bai I, Keyser C, Zhang Z, Rosolia B, Hwang JY, Zukin RS, Yan J. Epigenetic regulation of autophagy in neuroinflammation and synaptic plasticity. Front Immunol. 2024 Feb 22;15:1322842. [
DOI:10.3389/fimmu.2024.1322842] [
PMID] [
PMCID]
46. Zhang, J., Zhang, Y., Wang, J. et al. Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies. Sig Transduct Target Ther 9, 211 (2024). [
DOI:10.1038/s41392-024-01911-3] [
PMID] [
PMCID]
47. Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023 Feb 16;186(4):693-714. [
DOI:10.1016/j.cell.2022.12.032] [
PMID]
48. Kesidou E, Lagoudaki R, Touloumi O, Poulatsidou KN, Simeonidou C. Autophagy and neurodegenerative disorders. Neural Regen Res. 2013 Aug 25;8(24):2275-83.
49. Polajnar M, Zerovnik E. Impaired autophagy: a link between neurodegenerative and neuropsychiatric diseases. J Cell Mol Med. 2014 Sep;18(9):1705-11. [
DOI:10.1111/jcmm.12349] [
PMID] [
PMCID]
50. Lepeta K, Lourenco MV, Schweitzer BC, Martino Adami PV, Banerjee P, Catuara-Solarz S, de La Fuente Revenga M, Guillem AM, Haidar M, Ijomone OM, Nadorp B, Qi L, Perera ND, Refsgaard LK, Reid KM, Sabbar M, Sahoo A, Schaefer N, Sheean RK, Suska A, Verma R, Vicidomini C, Wright D, Zhang XD, Seidenbecher C. Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students. J Neurochem. 2016 Sep;138(6):785-805. [
DOI:10.1111/jnc.13713] [
PMID] [
PMCID]
51. Gao L, Jauregui CE, Teng Y. Targeting autophagy as a strategy for drug discovery and therapeutic modulation. Future Med Chem. 2017 Mar;9(3):335-345. [
DOI:10.4155/fmc-2016-0210] [
PMID]
52. Guo F, Liu X, Cai H, Le W. Autophagy in neurodegenerative diseases: pathogenesis and therapy. Brain Pathol. 2018 Jan;28(1):3-13. [
DOI:10.1111/bpa.12545] [
PMID] [
PMCID]
53. Jha NK, Chen WC, Kumar S, Dubey R, Tsai LW, Kar R, Jha SK, Gupta PK, Sharma A, Gundamaraju R, Pant K, Mani S, Singh SK, Maccioni RB, Datta T, Singh SK, Gupta G, Prasher P, Dua K, Dey A, Sharma C, Mughal YH, Ruokolainen J, Kesari KK, Ojha S. Molecular mechanisms of developmental pathways in neurological disorders: a pharmacological and therapeutic review. Open Biol. 2022 Mar;12(3):210289. [
DOI:10.1098/rsob.210289] [
PMID] [
PMCID]
54. Bjorkli C, Hemler M, Julian JB, Sandvig A, Sandvig I. Combined targeting of pathways regulating synaptic formation and autophagy attenuates Alzheimer's disease pathology in mice. Front Pharmacol. 2022 Aug 16;13:913971. [
DOI:10.3389/fphar.2022.913971] [
PMID] [
PMCID]
55. DeTure, M. A., and Dickson, D. W. The neuropathological diagnosis of Alzheimer's disease. Mol. Neurodegener. 2019,14 (1), 32. [
DOI:10.1186/s13024-019-0333-5] [
PMID] [
PMCID]
56. Young, J.E.; Martinez, R.A.; La Spada, A.R. Nutrient deprivation induces neuronal autophagy and implicates reduced insulin signaling in neuroprotective autophagy activation. J. Biol. Chem. 2009;284, 2363-2373. [
DOI:10.1074/jbc.M806088200] [
PMID] [
PMCID]
57. Yip, C.K.; Murata, K.; Walz, T.; Sabatini, D.M.; Kang, S.A. Structure of the human mTOR complex I and its implications for rapamycin inhibition. Mol. Cell 2010,38,768-774. [
DOI:10.1016/j.molcel.2010.05.017] [
PMID] [
PMCID]
58. Spilman, P.; Podlutskaya, N.; Hart, M.J.; Debnath, J.; Gorostiza, O.; Bredesen, D.; Richardson, A.; Strong, R.; Galvan, V. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS ONE 2010;5, e9979. [
DOI:10.1371/journal.pone.0009979] [
PMID] [
PMCID]
59. Wurth, R.; Barbieri, F.; Florio, T. New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells. BioMed Res. Int. 2014;126586. [
DOI:10.1155/2014/126586] [
PMID] [
PMCID]
60. Cameron, A.R.; Logie, L.; Patel, K.; Erhardt, S.; Bacon, S.; Middleton, P.; Harthill, J.; Forteath, C.; Coats, J.T.; Kerr, C.; et al. Metformin selectively targets redox control of complex I energy transduction. Redox Biol. 2018;14, 187-197. [
DOI:10.1016/j.redox.2017.08.018] [
PMID] [
PMCID]
61. Tamargo-Gomez, I.; Marino, G. AMPK: Regulation of Metabolic Dynamics in the Context of Autophagy. Int. J. Mol. Sci. 2018;19, 3812. [
DOI:10.3390/ijms19123812] [
PMID]
62. Zhang, C.S.; Li, M.; Ma, T.; Zong, Y.; Cui, J.; Feng, J.W.; Wu, Y.Q.; Lin, S.Y.; Lin, S.C. Metformin Activates AMPK through the Lysosomal Pathway. Cell Metab. 2016;24, 521-522. [
DOI:10.1016/j.cmet.2016.09.003] [
PMID]
63. Redmann M, Benavides GA, Berryhill TF, et al. Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial quality and bioenergetic function in primary neurons. Redox Biol. 2017. Apr;11: 73-81. [
DOI:10.1016/j.redox.2016.11.004] [
PMID] [
PMCID]
64. Mauthe M, Orhon I, Rocchi C, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14(8):1435-1455. [
DOI:10.1080/15548627.2018.1474314] [
PMID] [
PMCID]
65. Ding ZB, Hui B, Shi YH, et al. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clin Cancer Res. 2011;17(19):6229-6238. [
DOI:10.1158/1078-0432.CCR-11-0816] [
PMID]
66. Verbaanderd C, Maes H, Schaaf MB, et al. Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents. Ecancermedicalscience 2017; 11:781. [
DOI:10.3332/ecancer.2017.781] [
PMID] [
PMCID]
67. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012; 31:1095-108. [
DOI:10.1038/emboj.2012.32] [
PMID]
68. Martina JA, Chen Y, Gucek M, Puertollano R. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy. 2012; 8:903-14. [
DOI:10.4161/auto.19653] [
PMID]
69. Napolitano G, Ballabio A. TFEB at a glance. J Cell Sci. 2016;129:2475-81. [
DOI:10.1242/jcs.146365] [
PMID]
70. Szinyákovics, J., Keresztes, F., Kiss, E. A., Falcsik, G., Vellai, T., & Kovács, T. Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing. Cells, 2023;12(13), 1753. [
DOI:10.3390/cells12131753] [
PMID] [
PMCID]